Chad M. Michener - Concepedia

Author

Chad M. Michener

Cleveland Clinic ORCID

Also Known As

C Michener, C. M. Michener, C. Michener, C.M. MICHENER, C.M. Michener, Chad M Michener, Chad M. Michener, Chad Michener

197

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Cleveland Clinic Cleveland Clinic Lerner College of Medicine Case Western Reserve University Baylor College of Medicine Women’s Health Care

About

Chad M. Michener is an author at Cleveland Clinic specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	33	1.3K
2	Cell Biology	3	3	191
3	Public Health	2	2	90
4	Health Sciences	1	1	26
5	Nursing	1	1	22

Chad M. Michener

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer Laura Chambers, Emily Esakov Rhoades, Rashmi Bharti, Cancer Research	2022	113
Potential Markers for Detection and Monitoring of Ovarian Cancer Brandon J. D. Rein, Sajal Gupta, Rima Dada, Journal of Oncology Biomarker (Medicine)Cancer DetectionMedicinePathologyGynecology	2011	111
Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center Jessica Moline, Haider Mahdi, Bin Yang, Gynecologic Oncology Cancer DetectionMedicineGynecologyPathologyCytopathology	2013	102
Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival? Amanda N. Fader, Jennifer Bergstrom, Amelia Jernigan, Gynecologic Oncology Gynecologic SurgerySurgical OncologyPrimary Cytoreductive SurgeryGynecological SurgeryMedicine	2017	98
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors Caner Saygin, Andrew Wiechert, Vinay S. Rao, The Journal of Experimental Medicine Cisplatin ResistanceCancer ResearchLipid Raft LocalizationParallel Cisplatin ResistanceMedicine	2017	93
The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. Monica B. Jones, Chad M. Michener, James O. Blanchette, PubMed	2003	80
Endometrial cancer in young women: prognostic factors and treatment outcomes in women aged ≤40 years Ji Son, Caitlin Carr, Meng Yao, International Journal of Gynecological Cancer	2020	70
Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin–epithelin precursor (GEP), a prosurvival factor for ovarian cancer Mitchell Kamrava, Fiona Simpkins, Emilyn U. Alejandro, Oncogene MedicineCancer GrowthCancer Cell BiologyGynecologyLysophosphatidic Acid	2005	69
Surgical Site Infection in Women Undergoing Surgery for Gynecologic Cancer Haider Mahdi, Anar Gojayev, Megan Buechel, International Journal of Gynecological Cancer	2014	66
Germline <scp><i>PTEN</i></scp>, <scp><i>SDHB‐D</i></scp>, and <scp><i>KLLN</i></scp> alterations in endometrial cancer patients with Cowden and Cowden‐like syndromes: An international, multicenter, prospective study Haider Mahdi, Jessica L. Mester, Emily Nizialek, Cancer	2014	63

Page 1